SCHEMBL1148152

SCHEMBL1148152

COC(=O)C(C)C(Oc1ccc(Cl)cc1)C(=O)OC(C)(C)C

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPSR1 Q6W5P4 2/20 0.45
GAA P10253 1/20 0.45
GPR55 Q9Y2T6 1/20 0.45
MAPT P10636 4/20 0.41
MAPK1 P28482 2/20 0.41
ATM Q13315 2/20 0.41
GRIN2D O15399 1/20 0.40
GRIN3B O60391 1/20 0.40
GRIN1 Q05586 1/20 0.40
GRIN2A Q12879 1/20 0.40
GRIN2B Q13224 1/20 0.40
GRIN2C Q14957 1/20 0.40
GRIN3A Q8TCU5 1/20 0.40
CYP1A2 P05177 5/20 0.40
CYP3A4 P08684 5/20 0.40
CYP2C19 P33261 4/20 0.40
KMT2A Q03164 4/20 0.40
PPARA Q07869 3/20 0.40
MEN1 O00255 3/20 0.40
CYP2D6 P10635 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1148102 0.83 NPSR1 (0.42) NPSR1GAACYP1A2KMT2AMEN1
SCHEMBL21991494 0.79 GAA (0.44) NPSR1GAAGPR55MAPTCYP1A2
SCHEMBL23647604 0.77 KLK7 (0.46) NPSR1GAAGPR55MAPTCYP1A2
SCHEMBL11241834 0.76 PPARA (0.44) NPSR1GAAGPR55MAPTMAPK1
SCHEMBL9285601 0.75 MEN1 (0.58) NPSR1GAAGPR55MAPTCYP1A2
SCHEMBL18331472 0.75 MEN1 (0.58) NPSR1GAAGPR55MAPTCYP1A2
SCHEMBL21992627 0.75 L3MBTL1 (0.46) NPSR1GAAGPR55MAPTCYP1A2
SCHEMBL21992566 0.72 HPGD (0.57) NPSR1MAPTMAPK1ATMCYP1A2
SCHEMBL28264977 0.72 HPGD (0.46) NPSR1GAAGPR55MAPTCYP1A2
SCHEMBL5695197 0.71 GAA (0.42) NPSR1GAAGPR55MAPTCYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7884103-B2 such as N-(4-Chloro-phenyl)-2-methyl-2-phenylmethanesulfonylamino-3-(4-[1,2,4]triazol-1-yl-phenoxy)-propionamide, used for controlling or preventing the infestation of plants by phytopathogenic microorganisms, especially fungi SYNGENTA CROP PROTECTION, INC. (US) 2011-02-08 US disclosed
US-20070155748-A1 N-sulfonyl-alpha-amino-acid derivatives SYNGENTA CROP PROTECTION, INC. 2007-07-05 US disclosed
EP-1660441-A2 N-SULFONYL-ALPHA-AMINO-ACID DERIVATIVES Syngenta Participations AG (CH) 2006-05-31 EP disclosed
WO-2005021490-A2 N-SULFONYL-α-AMINO-ACID DERIVATIVES SYNGENTA PARTICIPATIONS AG (CH) 2005-03-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070155748-A1 N-sulfonyl-alpha-amino-acid derivatives C3AR1, GLRA1, C5AR1 NPSR1 780/4885GAA 4589/4885GPR55 331/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.